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Objectives: The purpose of this study was to evaluate two electrosurgical vessel-sealing devices in
biliary surgery.
Methods: Porcine common bile ducts (CBDs) were sealed with two electrosurgical devices, an electro-
thermal bipolar vessel-sealing device (EBVS) and ultrasonic coagulation shears. Acute study animals
underwent surgical bile duct sealing followed by immediate burst pressure testing. Chronic study animals
were maintained for 1 week postoperatively and then tested.
Results: The seal failure rate in the acute study was 50% for both the EBVS device and shears, and 0%
for the laparoscopic surgical clip device used as a control. The latter had significantly higher burst
pressures (646.2  281.8 mmHg; P = 0.006) than the EBVS device (97.6  86.6 mmHg) and shears
(71.7  89.3 mmHg). No significant difference in burst pressures was noted between the EBVS device
and shears (97.6  86.6 mmHg vs. 71.7  89.3 mmHg). In the chronic study, obvious bile leaks occurred
in one of four pigs (25%) in the EBVS device subgroup and two of four pigs (50%) in the shears subgroup.
The average proximal CBD pressure in seven pigs was 16.1  4.1 mmHg. The average chronic burst
pressure in the control subgroup was 1088.0  922.6 mmHg.
Conclusions: Given the high rates of failure of the EBVS device and the shears in consistently sealing
biliary ducts, we do not recommend their routine use in biliary surgery.
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Introduction
Hepatobiliary surgery has witnessed significant advances in tech-
nology and surgical techniques in the last decade, leading to the
safer and wider applicability of these procedures. A major break-
through in minimally invasive surgery has involved the novel
energy sources developed to help achieve haemostasis via vessel
sealing. These energy sources are reported to be safe and
efficacious1–3 and have been applied in many surgical disciplines,
including colorectal,4,5 endocrine,6 urological7 and gastrointestinal
surgery.8,9 Despite the publication of case reports and series using
novel electrosurgical devices in laparoscopic cholecystectomy,10,11
little is known about the efficacy of using these devices in the
biliary tract, specifically for sealing the cystic duct, and little objec-
tive evidence has emerged to support their use.
The importance and clinical relevance of these devices for use
in biliary tract surgery, specifically laparoscopic cholecystectomy,
refer to the issue of whether these devices can adequately seal the
cystic duct; if they can, this would allow the surgeon to use one
instrument for sealing the cystic duct and cystic artery, and for
dissecting the gallbladder from the liver bed, therefore making the
surgeon more efficient and possibly decreasing operating room
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time.12 The purpose of our study was to evaluate the use of two
commonly used electrosurgical devices, an electrothermal bipolar
vessel-sealing device (EBVS) and ultrasonic coagulation shears, in
biliary tract surgery.
Materials and methods
The experimental protocol was approved by the CarolinasMedical
Center Institutional Animal Care and Use Committee. Female
Yorkshire pigs (Baux Mountain Farm, Germanton, NC, USA)
weighing 40–50 kg were used in the experiments. Porcine
common bile ducts (CBDs) were sealed with one of two electro-
surgical devices: (i) a 5-mm laparoscopic EBVS device (LigaSure
Advance™; Valleylab, Inc., Boulder, CO, USA), and (ii) 5-mm
laparoscopic ultrasonic coagulation Harmonic ACE® shears (HS)
(Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA). A 10-mm
diameter laparoscopic surgical clip applier (LC) (Ligaclip® ERCA;
Ethicon Endo-Surgery, Inc.) was used as control. We chose the
CBD to test the sealing effect of the electrosurgical devices in order
to subject the resultant seals to the maximum conceivable burst
load in the form of largest accessible biliary structure and contin-
ued postoperative stress load caused by bile secretion. We believe
that if seals created by these instruments were shown to handle
this level of stress load, this would indicate that the instruments
were more than adequate for safe cholecystectomy and hepatic
resection.
All animals underwent a midline laparotomy under general
anaesthesia via endotracheal intubation. The first group (n = 11)
underwent surgical bile duct ligation followed immediately by
burst pressure testing of the proximal CBD stump; the animals
were killed after documentation of the data. The remaining group
of animals (n = 12) underwent surgical bile duct ligation after
which a 15-Fr, round, hubless, silicone Blake® drain (Ethicon, Inc.,
Piscataway, NJ, USA) connected externally to a 100-ml J-VAC
Bulb Suction Reservoir (Ethicon, Inc.) was placed in the proximity
of the sealed CBD before closure of the abdomen. These animals
were maintained for 1 week or until they developed signs of bile
leak, sepsis or failure to thrive. Animals were killed when bile was
noted at any time in the postoperative drainage. At the time of
procurement, a re-laparotomy was performed to facilitate the
examination of the CBD seal for integrity and burst pressure
testing. Burst pressure testing on the resected proximal CBD
stump was performed using a Cole-Parmer® automated syringe
pump (model SW-74900-00; Cole-Parmer Instrument Co.,
Vernon Hills, IL, USA) attached to a Fluke® pressure calibrator
(model 717-100G; Fluke Biomedical Corp., Everett, WA, USA)
depicted in Fig. 1. The pressure calibrator determines maximum
andminimum pressures in mmHg when saline is injected into the
lumen of a vessel or duct fixed to a pre-designed fixation device
using an iris clamp around the injection port (Fig. 2). Proximal
bile duct pressures were measured at necropsy using a Spacelabs
514 pressure monitor (Spacelabs Healthcare, Inc., Issaquah, WA,
USA) and transducer connected via a 22-gauge needle.
Statistical analysis was carried out using sas Version 9.1 (SAS
Institute, Inc., Cary, NC, USA). Means and standard deviations
were calculated for measurement variables and comparisons were
made using analysis of variance (anova) followed by Tukey tests
when appropriate. A P-value <0.05 was considered statistically
significant.
Results
In total, 23 pigs underwent surgical bile duct sealing. The acute
study included 11 pigs with bile ducts sealed by: the LC (n = 3);
the EBVS device (n = 4), and the HS device (n = 4). Common bile
duct burst pressures in the acute study are listed in Table 1. There
were no seal failures for the surgical clip (LC) subgroup, in which
the average burst pressure was 646.2 281.8 mmHg. Two of the
Figure 1 Instrumentation used for measuring common bile duct
burst pressure
Figure 2 Resected proximal bile duct in burst pressure testing
device
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four (50%) seals made using the EBVS device and two of the four
made using the HS in the acute study failed with a burst pressure
of <50 mmHg; average burst pressures were 97.6 86.6 mmHg
for EBVS seals and 71.7 89.3 mmHg for HS seals. The LC
was associated with significantly higher burst pressures than the
EBVS device (646.2 281.8 mmHg vs. 97.6 86.6 mmHg;
P = 0.006) and the HS device (646.2 281.8 mmHg vs.
71.7 89.3 mmHg; P = 0.006), but no difference in burst pres-
sure was observed between seals made with the EBVS and HS
devices (97.6 86.6 mmHg vs. 71.7 89.3 mmHg; P = 0.720), as
depicted in Fig. 3.
The chronic study included 12 pigs in which bile ducts were
sealed by the LC (n = 4), the EBVS device (n = 4) and the HS
device (n = 4). Outcomes and CBD pressures in the chronic study
are listed in Table 2. In the LC subgroup, two pigs were killed on
postoperative day 2 because of poor ad libitum food intake and
general failure to thrive. On exploration, both seals were intact
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Figure 3 Common bile duct burst pressures in acute study
subgroups. LC, Ligaclip® ERCA; EBVS, LigaSure Advance™; HS,
Harmonic ACE®. LC, P = 0.006; EBVS, P = 0.720; HS, P = 0.720
Table 1 Acute study: common bile duct burst pressures in 11 pigs
Sealing device CBD burst pressure, mmHg Mean  SD, mmHg P-value
Ligaclip® ERCA (LC) 690.8 646.2  281.8 0.006
903.0
344.8
LigaSure Advance™ (EBVS) 123.4 97.6  86.6 0.720
0.0
1.0
168.3
Harmonic ACE® (HS) 90.4 71.7  89.3
190.4
4.8
1.0
CBD, common bile duct; SD, standard deviation
Table 2 Chronic study: outcomes and common bile duct burst pressures in 12 pigs
Sealing device CBD burst pressure,
mmHg
Proximal CBD stump
pressure, mmHg
Outcomes
Ligaclip® ERCA (LC) 58.6 19.0 Mean CBD burst pressure 1088.0  922.6 mmHg
and mean proximal CBD pressure
16.1  4.1 mmHg; no bile leaks
Two of four animals killed on POD 2 for failure to
thrive
1675.4 20.0
584.0 13.0
2034.0 10.0
LigaSure Advance™ (EBVS) N/A 18.0 One animal killed on POD 1 for bile leak; other three
showed no gross bile leak, but CBD seals
disrupted during exploration
N/A 20.0
N/A N/A
N/A N/A
Harmonic ACE® (HS) N/A 13.0 Two of four animals killed on POD 3 for bile leak;
other two showed no gross bile leak, but CBD
seals disrupted during exploration
N/A N/A
N/A N/A
N/A N/A
CBD, common bile duct; N/A, not able to be tested; POD, postoperative day
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with no disruption. Both animals had grossly distended stomachs
with no obvious obstruction. The other two pigs completed the
7-day study. Average CBD burst pressure in the LC subgroup was
1088.0 922.6 mmHg.
One pig in the EBVS device subgroup (n = 4) was killed on
postoperative day 1 because of an obvious bile leak; a proximal
bile duct disruption was identified on exploration. The remaining
three pigs completed the 7-day study without gross leakage;
however, bile ducts were disrupted upon minimal dissection and
we were unable to obtain any burst pressures.
In the HS subgroup, two pigs were killed on postoperative day
3 because of obvious bile leaks in the drain; leaks at the proximal
CBD were identified on exploration. The other two pigs com-
pleted the 7-day study without a gross leak; however, bile ducts
were disrupted upon minimal dissection and we were unable to
obtain burst pressures.
In the chronic study, we were able to obtain proximal bile duct
pressures measured on postoperative day 7 in seven pigs (four in
the LC, two in the EBVS and one in the HS subgroups). The
average proximal CBD pressure was 16.1 4.1 mmHg.
Discussion
The ability to obtain haemostasis using electrosurgical vessel-
sealing devices has represented a great advance in the fields of
both open and laparoscopic hepatobiliary surgery. Establishing
haemostasis is critical to improving clinical outcomes and provid-
ing a clear field for adequate visualization. Although these energy
sources have a proven safety and efficacy profile for haemostasis in
appropriately sized arteries and veins, their efficacy in sealing bile
ducts is unproven and currently surgical clips, which are associ-
ated with a low complication rate, remain the most commonly
used device to ligate the cystic duct. Secondary to this, clips served
as the control in this experiment.
There are several theoretical attractions of using a single elec-
trosurgical device to seal blood vessels as well as biliary ducts in
hepatobiliary surgical procedures. Firstly, the use of a single
instrument may potentially decrease operative time and costs
because it decreases the number of instrument exchanges in lap-
aroscopic surgery and allows one instrument to be used through-
out the entire procedure in a fast and efficient manner for multiple
applications, including the ligation of appropriately sized blood
vessels and biliary structures, the parenchymal transection of liver
and the dissection of the gallbladder. Secondly, newer electrother-
mal surgical devices are associated with a potential reduction in
‘thermal spread’ compared with older monopolar and bipolar
instruments used during laparoscopic cholecystectomy.
Two commonly used energy sources for laparoscopic surgery
are the EBVS and HS devices. This study may be limited by its use
of only two electrosurgical devices because several other instru-
ments with different mechanisms of action that could potentially
be used for sealing the cystic duct are available. The rationale
behind using these two electrosurgical devices, which have differ-
ent mechanisms of action, was that these are the two products
cited in the literature as being most commonly used for sealing
cystic ducts during laparoscopic cholecystectomy.13,14When evalu-
ating these products, it is important to understand the indications
for their use and their mechanisms of action. The EBVS device
is a feedback-controlled, high-current (4 amps), low-voltage
(<200 volts) bipolar instrument.15 The high current denatures the
collagen and elastin in the tissue bundles and vessels, which then
quickly reform to create a ‘plastic-like’ seal zone following each
cycle of activation of the device. The LigaSure Advance™ is a
new-generation EBVS device designed for increased speed of
transection and is approved to seal vessels up to 7 mm in diameter.
It also has a monopolar tip on one of the jaws to assist with
dissection.
The HS device converts electrical energy into mechanical vibra-
tions via the transfer of high-frequency ultrasonic waves
(55 500 cycles/second [Hz]) to a vibrating blade for tissue division
and blood vessel coagulation.16 At relatively low temperatures (50–
100 °C), the mechanical vibrations disrupt hydrogen bonds in
tissue and vessel protein to form a coagulum. The Harmonic
ACE® is a new-generation product approved for use in vessels of
5 mm in diameter and is reported to have increased speed of
transection compared with previous generations of harmonic
scalpels.
Several reports document the safe use of the HS during laparo-
scopic cholecystectomy in humans for gallbladder removal, but
not cystic duct sealing.10,11,17–19 Power et al. used the HS for dissec-
tion of the gallbladder in 282 consecutive cases with a mean oper-
ating time of 29 min, reporting two bile leaks related to clipping of
the cystic duct.19 Fullum et al. used the HS for ‘dome-down dis-
section’ of the gallbladder and division of the cystic artery, with
division of the cystic duct accomplished by using two size 2–0
polydioxanone endoloops.10 These authors reported a mean oper-
ating time of 55 min, a conversion rate of 7.6%, and no bile duct
injuries. In one of the largest studies reported to date (a prospec-
tive non-randomized trial of 461 consecutive patients undergoing
laparoscopic cholecystectomy by Hüscher et al.), the entire opera-
tion including cystic duct and artery transection was performed in
331 patients using the HS device alone, and in 130 patients using
the HS for coagulation and division of the cystic duct and artery,
after which the cystic duct stump was secured with an absorbable
suture endoloop. The authors reported no significant difference in
postoperative mortality, complications and/or cystic duct leaks.18
To date, the safety and efficacy of the EBVS device in biliary
tract surgery remain the subject of debate: several authors have
reported favourable results20–22 and others discourage its use based
on seal failures and increased rates of necrosis of cystic duct
stump23,24 in preclinical studies. Despite the previous reports of
success using the HS and EBVS devices in biliary tract surgery, our
data do not support their use for sealing the cystic duct. Of par-
ticular note was the measurement of proximal CBD pressure at 1
week (16.1 4.1 mmHg), a value that represents the pressure the
seal must withstand in the postoperative period. Although several
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of the seals made using the EBVS and HS devices in the acute
group withstood pressures well above this level, we cannot recom-
mend these devices because of the frequency of gross seal failures
seen in the chronic study, which amounted to 50% of seals made
using the HS and 25% of seals made using the EBVS device. The
failure with minimal dissection of the remaining seals made with
the HS and EBVS devices in the chronic study suggests that these
were leaks sealed by omentum or surrounding tissues, and were
not detected clinically. This gives an essential seal failure rate of
100% in the chronic study for both instruments.
The major limitation of our study concerns our use of the
porcine CBD as a surrogate for the human cystic duct. The diam-
eters of the porcine CBDs ranged from 5.6 mm to 6.8 mm, slightly
larger than that of the typical human cystic duct. We chose the
porcine CBDbecause a previous study23 reported sizes comparable
with those of the human cystic duct.An additional problemmay lie
in the fact that dissection of a porcine cystic duct is technically
difficult because of its relatively small size and intrahepatic loca-
tion. As such, sealing the porcine common duct creates a clinically
unrealistic pressure because the sealmust withstand the intralumi-
nal pressure contributed by the entire hepatic bile secretory output.
This pressure is likely to be significantly higher than that occurring
in the cystic duct stump or small bile duct ends exposed during
hepatic parenchymal transection. The rationale for using the CBD
was that if the electrosurgical vessel-sealingdeviceswere able to seal
the CBD, with its increased size and presumed increased pressure,
we could assume that they would safely and effectively seal smaller
biliary structures, including the cystic duct and intrahepatic bile
ducts. As such, although our data cannot support the use of these
electrosurgical devices alone for sealing biliary structures, our
study design represents the most extreme case scenario for human
cystic ducts. Further study is needed to specifically test cystic duct
seals in cholecystectomy and intrahepatic bile duct seals in liver
resection,and tofindanappropriate surrogate for thehumancystic
duct or intrahepatic bile duct. The question of why these electro-
surgical devices can adequately seal blood vessels of up to 7 mm in
size, yet fail to seal biliary structures of comparable size, remains.
One potential explanation is related to the unique properties of the
protein matrix in the bile duct wall or the absence of a thrombo-
genic coagulum that occurs when ligating vascular structures, as
hypothesized by Matthews and colleagues.23 In EBVS devices,
changes in the power output algorithm may provide improved
sealing of non-blood vessel structures. Unfortunately, the histo-
logical evaluations in this study were insufficient to allow us to
comment on why the seals may have failed, but this will be
addressed in future studies. Lastly, this study represents a pilot
study to assess clinically and objectively the efficacy of these two
electrosurgical devices and therefore is underpowered to draw
definitive conclusions on the use of these devices in biliary tract
surgery.
In conclusion, the development of the HS and EBVS devices
represent a major breakthrough in surgery, facilitating haemosta-
sis in 5–7-mm blood vessels. Despite improvements in the effi-
ciency and vessel-sealing capabilities of these two new-generation
electrosurgical devices, we do not recommend the Harmonic
ACE® or LigaSure Advance™ alone for use in sealing biliary struc-
tures because of the high failure rate associated with the seal. Our
study is limited by our use of the porcine CBD, which may not be
an ideal surrogate for the human cystic duct or intrahepatic biliary
duct. Preclinical and clinical studies evaluating the use of these
devices in sealing cystic ducts in cholecystectomy and biliary
pedicles in hepatic resections are needed. Further study is needed
to determine the mechanisms whereby bile ducts are resistant to
sealing using current electrosurgical devices, and to potentially
find new sealing algorithms for the electrothermal bipolar vessel-
sealing devices to facilitate open and, particularly, laparoscopic
hepatobiliary surgery.
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